DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 6, Pages e0130651
Publisher
Public Library of Science (PLoS)
Online
2015-06-19
DOI
10.1371/journal.pone.0130651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methylation gene-based models indicating independent poor outcome in prostate cancer
- (2014) Nataša Vasiljević et al. BMC CANCER
- Prognostic DNA Methylation Markers for Prostate Cancer
- (2014) Siri Strand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Methylation markers for prostate cancer prognosis: a systematic review
- (2013) Chun Chao et al. CANCER CAUSES & CONTROL
- Results of surgery for high-risk prostate cancer
- (2013) Steven Joniau et al. CURRENT OPINION IN UROLOGY
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
- (2013) Charis Kalogirou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
- (2013) Christa Haldrup et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases
- (2013) M. J. Aryee et al. Science Translational Medicine
- Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience
- (2013) Sophie D. Fosså et al. UROLOGY
- Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
- (2012) K. Kron et al. CLINICAL CANCER RESEARCH
- Global Methylation Profiling for Risk Prediction of Prostate Cancer
- (2012) S. Mahapatra et al. CLINICAL CANCER RESEARCH
- Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion
- (2012) Maciej Salagierski et al. JOURNAL OF UROLOGY
- MiR-133b Targets Antiapoptotic Genes and Enhances Death Receptor-Induced Apoptosis
- (2012) Juan P. Patron et al. PLoS One
- Genome-wide DNA Methylation Events in TMPRSS2–ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
- (2012) Stefan T. Börno et al. Cancer Discovery
- Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences
- (2011) Srinivasan Yegnasubramanian et al. BMC GENOMICS
- Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
- (2011) J. Devaney et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer
- (2011) Sun Jung Kim et al. CANCER LETTERS
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
- (2011) T. W. Friedlander et al. CANCER RESEARCH
- A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer
- (2011) Jacob Schwartzman et al. Epigenetics
- Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer
- (2011) J. H. Kim et al. GENOME RESEARCH
- DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer
- (2011) Y. Kobayashi et al. GENOME RESEARCH
- Silencing ofGSTP1, a Prostate Cancer Prognostic Gene, by the Estrogen Receptor-β and Endothelial Nitric Oxide Synthase Complex
- (2011) A. Re et al. MOLECULAR ENDOCRINOLOGY
- Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells
- (2011) Hao Wu et al. NATURE
- The Epigenetic promise for prostate cancer diagnosis
- (2011) Leander Van Neste et al. PROSTATE
- Methylated genes as potential biomarkers in prostate cancer
- (2010) Veronique Phé et al. BJU INTERNATIONAL
- Global Methylation Pattern of Genes in Androgen-Sensitive and Androgen-Independent Prostate Cancer Cells
- (2010) D. K. Mishra et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- The epigenome as a therapeutic target in prostate cancer
- (2010) Antoinette S. Perry et al. Nature Reviews Urology
- The implications of heterogeneous DNA methylation for the accurate quantification of methylation
- (2010) Thomas Mikeska et al. Epigenomics
- Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients
- (2009) Lorenzo Richiardi et al. JOURNAL OF CLINICAL ONCOLOGY
- CpG Island Hypermethylation at Multiple Gene Sites in Diagnosis and Prognosis of Prostate Cancer
- (2008) Jörg Ellinger et al. UROLOGY
- Effect of DNA Methylation on Identification of Aggressive Prostate Cancer
- (2008) Joshi J. Alumkal et al. UROLOGY
- High-risk prostate cancer in the United States, 1990–2007
- (2008) Matthew R. Cooperberg et al. WORLD JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now